Back to Search
JUN RO, M.D.
M.D.
Family Medicine Physician
NPI: 1669404760IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
50671(GA)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
MEDICAL COLLEGE OF OHIO
Class of 1998
Research & Publications (20)
Primary systemic therapy with intermittent weekly paclitaxel plus gemcitabine in patients with stage II and III breast cancer: a phase II trial.
PMID 19229476·Invest New Drugs·2010
3-trial
Comparison of subtypes of penile squamous cell carcinoma from high and low incidence geographical regions.
PMID 19578046·Int J Surg Pathol·2010
4-observational
Phase II study of gemcitabine in combination with vinorelbine versus gemcitabine followed by vinorelbine for metastatic breast cancer.
PMID 19575146·Invest New Drugs·2010
3-trial
Fatty fish and fish omega-3 fatty acid intakes decrease the breast cancer risk: a case-control study.
PMID 19566923·BMC Cancer·2009
7-preclinical
Celastrol suppresses allergen-induced airway inflammation in a mouse allergic asthma model.
PMID 19356734·Eur J Pharmacol·2009
7-preclinical
Virtual-karyotyping with SNP microarrays in morphologically challenging renal cell neoplasms: a practical and useful diagnostic modality.
PMID 19461508·Am J Surg Pathol·2009
8-other
Potential antitumor effects of nitrogen-containing bisphosphonate in hormone receptor negative breast cancer patients with bone metastases.
PMID 19454038·BMC Cancer·2009
8-other
PAX-2 in the diagnosis of primary renal tumors: immunohistochemical comparison with renal cell carcinoma marker antigen and kidney-specific cadherin.
PMID 19228645·Am J Clin Pathol·2009
8-other
Limited sampling of radical prostatectomy specimens with excellent preservation of prognostic parameters of prostate cancer.
PMID 19653726·Arch Pathol Lab Med·2009
8-other
Oncocytic papillary renal cell carcinoma with inverted nuclear pattern: distinct subtype with an indolent clinical course.
PMID 19261090·Pathol Int·2009
8-other
Cytokine production through PKC/p38 signaling pathways, not through JAK/STAT1 pathway, in mast cells stimulated with IFNgamma.
PMID 19231233·Cytokine·2009
7-preclinical
Celastrol binds to ERK and inhibits FcepsilonRI signaling to exert an anti-allergic effect.
PMID 19356729·Eur J Pharmacol·2009
7-preclinical
Simvastatin inhibits induction of matrix metalloproteinase-9 in rat alveolar macrophages exposed to cigarette smoke extract.
PMID 19299917·Exp Mol Med·2009
7-preclinical
Clinicopathologic features of renal cell carcinoma in young adults: a comparison study with renal cell carcinoma in older patients.
PMID 19294008·Int J Clin Exp Pathol·2009
8-other
Immunohistochemical comparison of chordoma with chondrosarcoma, myxopapillary ependymoma, and chordoid meningioma.
PMID 19521276·Appl Immunohistochem Mol Morphol·2009
4-observational
Activation of TRPV1 and TRPA1 leads to muscle nociception and mechanical hyperalgesia.
PMID 19464796·Pain·2009
7-preclinical
SP600125, an inhibitor of Jnk pathway, reduces viability of relatively resistant cancer cells to doxorubicin.
PMID 19607816·Biochem Biophys Res Commun·2009
7-preclinical
Bacillus calmette-guerin granuloma in seminal vesicle: report of the first case in the english literature.
PMID 19636407·Int J Clin Exp Pathol·2009
8-other
Number of lymph nodes examined and associated clinicopathologic factors in colorectal carcinoma.
PMID 19415953·Arch Pathol Lab Med·2009
8-other
Dedifferentiated liposarcoma with peculiar meningothelial-like whorling and metaplastic bone formation.
PMID 19608088·Ann Diagn Pathol·2009
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6335 HOSPITAL PKWY, STE 101
JOHNS CREEK, GA 30097 - Phone
- (770) 814-9672
Quick Facts
- NPI
- 1669404760
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 28
- Publications
- 20
Are you this provider?
Claim Your Profile